SuttonBrook Capital Management as of Dec. 31, 2010
Portfolio Holdings for SuttonBrook Capital Management
SuttonBrook Capital Management holds 48 positions in its portfolio as reported in the December 2010 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Genzyme Corporation | 10.6 | $68M | 951k | 71.20 | |
| Howard Hughes | 5.8 | $37M | 688k | 54.42 | |
| Massey Energy Company | 5.5 | $35M | 653k | 53.65 | |
| Vivus | 5.4 | $35M | 3.7M | 9.37 | |
| MGM Resorts International. (MGM) | 5.3 | $34M | 2.3M | 14.85 | |
| E TRADE Financial Corporation | 5.2 | $33M | 2.1M | 16.00 | |
| Mbia (MBI) | 4.7 | $30M | 217k | 139.00 | |
| General Mtrs Co jr pfd cnv srb | 4.6 | $30M | 550k | 53.91 | |
| E M C Corp Mass note 1.750%12/0 | 4.5 | $29M | 20M | 1.45 | |
| CommScope | 4.5 | $29M | 913k | 31.22 | |
| Endo Pharmaceuticals Hldgs I note 1.750% 4/1 | 4.2 | $27M | 20M | 1.33 | |
| Airgas | 4.0 | $26M | 556k | 45.91 | |
| Beckman Coulter | 3.1 | $20M | 265k | 75.23 | |
| Micron Technology Inc note 4.250%10/1 | 2.7 | $18M | 10M | 1.75 | |
| Symantec Corporation | 2.6 | $17M | 1.0M | 16.74 | |
| Financial Select Sector SPDR (XLF) | 2.5 | $16M | 1.0M | 15.95 | |
| Cubist Pharmaceuticals | 2.4 | $16M | 722k | 21.40 | |
| Sara Lee | 1.8 | $12M | 665k | 17.51 | |
| Bank of America Corporation (BAC) | 1.6 | $10M | 750k | 13.34 | |
| Elan Corporation | 1.4 | $8.8M | 1.5M | 5.73 | |
| Sprint Nextel Corporation | 1.3 | $8.5M | 2.0M | 4.23 | |
| Mosaic Company | 1.2 | $7.6M | 99k | 76.36 | |
| Pride International | 1.0 | $6.6M | 200k | 33.00 | |
| Pain Therapeutics | 1.0 | $6.5M | 960k | 6.75 | |
| Inspire Pharmaceuticals | 0.9 | $6.0M | 709k | 8.40 | |
| VCA Antech | 0.9 | $5.7M | 243k | 23.29 | |
| Warner Chilcott Plc - | 0.8 | $5.2M | 231k | 22.56 | |
| NPS Pharmaceuticals | 0.8 | $5.2M | 660k | 7.90 | |
| Exelixis (EXEL) | 0.7 | $4.5M | 554k | 8.21 | |
| Seagate Technology Com Stk | 0.7 | $4.5M | 300k | 15.03 | |
| Idenix Pharmaceuticals | 0.7 | $4.5M | 892k | 5.04 | |
| Cardiome Pharma Corp | 0.7 | $4.4M | 682k | 6.42 | |
| Goldman Sachs (GS) | 0.7 | $4.2M | 25k | 168.16 | |
| Amylin Pharmaceuticals | 0.7 | $4.2M | 288k | 14.71 | |
| NuVasive | 0.6 | $4.1M | 160k | 25.65 | |
| Medivation | 0.6 | $3.8M | 249k | 15.17 | |
| Amarin Corporation (AMRN) | 0.6 | $3.7M | 450k | 8.20 | |
| Thoratec Corporation | 0.5 | $3.4M | 120k | 28.32 | |
| Volcano Corporation | 0.5 | $3.2M | 117k | 27.31 | |
| Santarus | 0.5 | $3.2M | 970k | 3.27 | |
| Chelsea Therapeutics International | 0.5 | $3.0M | 400k | 7.50 | |
| Savient Pharmaceuticals | 0.4 | $2.6M | 230k | 11.14 | |
| Zions Bancorporation *w exp 05/22/202 | 0.3 | $2.2M | 300k | 7.36 | |
| Life Technologies | 0.3 | $1.8M | 32k | 55.51 | |
| Affymax (AFFY) | 0.2 | $1.4M | 210k | 6.65 | |
| Spdr S&p 500 Etf (SPY) | 0.2 | $1.4M | 15k | 91.33 | |
| DURECT Corporation | 0.2 | $1.0M | 300k | 3.45 | |
| Borders (BGP) | 0.1 | $900k | 1.0M | 0.90 |
